EYEDOCAINE
Live / Allowed — Published for opposition (as of 04 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 05 Jan 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99578101
- Mark type
- Stylized text
- Filed
- 05 Jan 2026
- Published for opposition
- 04 Aug 2026
- Attorney of record
- Thomas J. Durling
Goods and services
- Class 005 — Pharmaceuticals: Medical apparatus for topical administration and application of anesthetic medication as part of ophthalmological procedures, sold filled with topical anesthetics
- Class 010 — Medical apparatus: Medical apparatus for topical administration and application of anesthetic medication as part of ophthalmological procedures, sold empty; Medical apparatus for topical administration and application of anesthetic medication as part of ophthalmological procedures and topical anesthetics, sold as a unit
Owner
- Eyedocaine, Inc., Philadelphia, PA, US
- Eyedocaine, Inc., Philadelphia, PA, US
Prosecution history
- 04 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Aug 2026 — PUBLISHED FOR OPPOSITION
- 29 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Jul 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Jul 2026 — ASSIGNED TO LIE
- 30 Jun 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 May 2026 — NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 05 May 2026 — EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 05 May 2026 — COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
- 05 May 2026 — EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED